Status:

COMPLETED

PET Study With 11 C-PIB to Evaluate Amyloid Protein Deposits in Mild Cognitive Disorder, Alzheimer's Disease and Early Frontotemporal Degeneration.

Lead Sponsor:

IRCCS San Raffaele

Conditions:

Alzheimer Disease

Eligibility:

All Genders

40-80 years

Brief Summary

Preclinical and clinical data have demonstrated the ability of the 11C-PIB tracer to selectively bind accumulations of amyloid protein, a neuropathological marker characteristic of the neurodegenerati...

Eligibility Criteria

Inclusion

  • Alzheimer's diagnosis according to the diagnostic criteria in use.

Exclusion

  • current or previous treatments with neuroactive drugs;
  • pregnancy or breastfeeding.

Key Trial Info

Start Date :

May 17 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 15 2008

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06179979

Start Date

May 17 2008

End Date

July 15 2008

Last Update

December 22 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

PET Study With 11 C-PIB to Evaluate Amyloid Protein Deposits in Mild Cognitive Disorder, Alzheimer's Disease and Early Frontotemporal Degeneration. | DecenTrialz